INFORMATION FOR NEIMETH INTERNATIONAL PHARMACEUTICALS PLC
Current as of February 26, 2025
| Ticker Symbol | NEIMETH |
| Company Name | NEIMETH INTERNATIONAL PHARMACEUTICALS PLC |
| Industry Sector | Health technology |
| Market Cap (₦) | ₦13,246,623,518.00 |
| Outstanding Shares | 4,273,100,000.00 |
| Current Price (₦) | ₦3.03 |
| Price Change (₦) | ₦-0.07 |
| Price Change (%) | -2.26 |
| Volume | 666,696.00 |
| 1-Week Performance (%) | -9.55 |
| 1-Month Performance (%) | -10.62 |
| 1-Year Performance (%) | 68.33 |
| Dividend Yield (%) | 0.0 |
| P/E Ratio | nan |
| P/S Ratio | nan |
| Total Revenue (₦) | ₦4,468,519,000.00 |
| YoY Revenue Growth Rate (%) | 102.23 |
| TTM Gross profit (₦) | ₦2,050,736,000.00 |
| Operating margin | 19.10 |
| Net margin | -38.03 |
| Earning Per Share (₦) | ₦-0.40 |
| Total Assets (₦) | ₦9,917,827,000.00 |
| Total Liabilities (₦) | ₦10,147,762,000.00 |
| Net Debt (₦) | ₦3,170,338,000.00 |
| Free cash flow (₦) | ₦817,519,000.00 |